Screener
Kiniksa Pharmaceuticals International, plc KNSA Total Liabilities & Equity
Total Liabilities & Equity at other companies
Other financials
Where this comes from
Reported directly by Kiniksa Pharmaceuticals International, plc in its filing.
Tagged under the XBRL concept us-gaap:LiabilitiesAndStockholdersEquity.
The source filing: Kiniksa Pharmaceuticals International, plc’s 10-Q, filed July 28, 2026.
- Filed
- Jul 28, 2026, 4:17 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001104659-26-087545
| Line item | June 30, 2026 | December 31, 2025 |
|---|---|---|
| Class B ordinary shares, nominal value of $0.000273235 per share; 895,158 shares and 1,795,158 shares issued and outstanding as of June 30, 2026 and December 31, 2025, respectively | 1 | 1 |
| Class A1 ordinary shares, nominal value of $0.000273235 per share; 12,781,964 shares issued and outstanding as of June 30, 2026 and December 31, 2025 | 4 | 4 |
| Class B1 ordinary shares, $0.000273235 nominal value; 16,057,618 shares issued and outstanding as of June 30, 2026 and December 31, 2025 | 4 | 4 |
| Additional paid-in capital | 1,069,622 | 1,029,748 |
| Accumulated other comprehensive loss | (1,380) | (25) |
| Accumulated deficit | (414,114) | (462,138) |
| Total shareholders’ equity | 654,149 | 567,606 |
| Total liabilities and shareholders’ equity | $896,110 | $763,633 |
Item 1. Financial Statements (unaudited)
FAQ
- What is Kiniksa Pharmaceuticals International, plc's total liabilities & equity?
- Kiniksa Pharmaceuticals International, plc (KNSA) reported total liabilities & equity of $896.11M in Q2 2026.
- How has Kiniksa Pharmaceuticals International, plc's total liabilities & equity changed year-over-year?
- Kiniksa Pharmaceuticals International, plc's total liabilities & equity increased by 35.5% year-over-year, from $661.15M to $896.11M.
- What is the long-term trend for Kiniksa Pharmaceuticals International, plc's total liabilities & equity?
- Over 5 years (2020 to 2025), Kiniksa Pharmaceuticals International, plc's total liabilities & equity has grown at a 16.9% compound annual growth rate (CAGR), from $349.46M to $763.63M.
- What does total liabilities & equity mean?
- Total assets = total liabilities + total equity. This must always balance — a fundamental accounting identity.
Ask your AI about Kiniksa Pharmaceuticals International, plc's total liabilities & equity.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude